EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

T Cell Heterogeneity Shaped by Alternative Splicing Predicts Prognosis in Hepatocellular Carcinoma

Xiaohui Peng, Zhenli Li, Xiuqing Dong, Zhixiong Cai, Chenfan Lu, Junjie Gao, Shuyue You, Yuwen Wang, Jianming Mao, Xiaolong Liu iD, Geng Chen, Yingchao Wang iD

Cancer Science · 2026

DOI: 10.1111/cas.70394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2026. Verfasst von Xiaohui Peng und 11 weiteren Autor:innen. Beteiligte Einrichtung: The School of Public Health, Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Alternative Splicing, T-Lymphocytes. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Fujian Province, Fujian Provincial Health Science and Technology Plan Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alternative splicing (AS) plays a key role in the regulation of immune function and cellular heterogeneity. However, its impact on T‐cell behavior and clinical outcomes in hepatocellular carcinoma (HCC) remains poorly understood. Single‐cell full‐length transcriptome data were used to obtain comprehensive splicing site information. Variable AS events were identified in each cell using the SCASL algorithm, and AS‐based profiles were constructed. Based on this, differential expression, functional enrichment, cell interaction, and RNA velocity analyses were used to reveal functional differences among distinct cell populations based on AS profiles. Finally, based on the functional differences among distinct T‐cell subpopulations, an AS event‐based survival prognosis model was constructed to assess patient outcomes. Using the SCASL algorithm, major cell subpopulations were identified and T cells were further divided into two AS‐based subtypes distinct from gene expression clustering. Functional analysis revealed that these subtypes were enriched in NOD‐like receptors, C‐type lectin receptors, T‐cell receptor signaling, antigen processing and presentation, and other immune‐related pathways. Based on the definition of AS events, we constructed a prognostic model capable of distinguishing between patients with different risk levels, which was further validated using public datasets. Collectively, our findings highlight the crucial role of AS in shaping T‐cell functional heterogeneity, and the AS‐based prognostic model we established further underscores its clinical relevance, providing novel insights into tumor–immune interactions and uncovering potential splicing‐derived biomarkers for immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularAlternative SplicingT-LymphocytesHumansPrognosisGene Expression Regulation, NeoplasticGene Expression ProfilingTranscriptomeSingle-Cell Gene Expression AnalysisBiomarkers, TumorAlgorithms

Stichwörter der Autor:innen

T‐cell immunityalternative splicinghepatocellular carcinomaprognosistumor immune microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • The School of Public Health, Fujian Medical University, Fuzhou, China.
  • The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.

ORCID-Profile: Xiaolong Liu, Yingchao Wang

Förderung

  • Natural Science Foundation of Fujian Province
  • Fujian Provincial Health Science and Technology Plan Project
  • National Natural Science Foundation of China

Zitieren

APA

Peng, X., Li, Z., Dong, X., Cai, Z., Lu, C., Gao, J., You, S., Wang, Y., Mao, J., Liu, X., Chen, G., & Wang, Y. (2026). T Cell Heterogeneity Shaped by Alternative Splicing Predicts Prognosis in Hepatocellular Carcinoma. Cancer Science. https://doi.org/10.1111/cas.70394

Vancouver

Peng X, Li Z, Dong X, Cai Z, Lu C, Gao J, et al. T Cell Heterogeneity Shaped by Alternative Splicing Predicts Prognosis in Hepatocellular Carcinoma. Cancer Science. 2026. doi:10.1111/cas.70394

BibTeX
@article{Peng2026,
  author = {Peng, Xiaohui and Li, Zhenli and Dong, Xiuqing and Cai, Zhixiong and Lu, Chenfan and Gao, Junjie and You, Shuyue and Wang, Yuwen and Mao, Jianming and Liu, Xiaolong and Chen, Geng and Wang, Yingchao},
  title = {T Cell Heterogeneity Shaped by Alternative Splicing Predicts Prognosis in Hepatocellular Carcinoma},
  journal = {Cancer Science},
  year = {2026},
  doi = {10.1111/cas.70394}
}
Kostenlos starten →